- Home
- NKTR vs AGD Comparison
NKTR vs AGD Comparison
Compare NKTR & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- AGD
- Stock Information
- Founded
- NKTR 1990
- AGD 2006
- Country
- NKTR United States
- AGD United Kingdom
- Employees
- NKTR N/A
- AGD N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- AGD Trusts Except Educational Religious and Charitable
- Sector
- NKTR Health Care
- AGD Finance
- Exchange
- NKTR Nasdaq
- AGD Nasdaq
- Market Cap
- NKTR 247.9M
- AGD 244.8M
- IPO Year
- NKTR 1994
- AGD N/A
- Fundamental
- Price
- NKTR $0.90
- AGD $10.32
- Analyst Decision
- NKTR Strong Buy
- AGD
- Analyst Count
- NKTR 5
- AGD 0
- Target Price
- NKTR $4.50
- AGD N/A
- AVG Volume (30 Days)
- NKTR 1.5M
- AGD 61.2K
- Earning Date
- NKTR 03-03-2025
- AGD 01-01-0001
- Dividend Yield
- NKTR N/A
- AGD 8.13%
- EPS Growth
- NKTR N/A
- AGD N/A
- EPS
- NKTR N/A
- AGD N/A
- Revenue
- NKTR $93,137,000.00
- AGD N/A
- Revenue This Year
- NKTR $12.85
- AGD N/A
- Revenue Next Year
- NKTR N/A
- AGD N/A
- P/E Ratio
- NKTR N/A
- AGD N/A
- Revenue Growth
- NKTR 5.53
- AGD N/A
- 52 Week Low
- NKTR $0.50
- AGD $8.20
- 52 Week High
- NKTR $1.93
- AGD $9.78
- Technical
- Relative Strength Index (RSI)
- NKTR 40.16
- AGD 65.86
- Support Level
- NKTR $0.87
- AGD $9.71
- Resistance Level
- NKTR $0.94
- AGD $10.00
- Average True Range (ATR)
- NKTR 0.09
- AGD 0.12
- MACD
- NKTR -0.01
- AGD 0.06
- Stochastic Oscillator
- NKTR 15.63
- AGD 100.00
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current dividend income. The Fund also focuses on the long-term growth of capital as a secondary investment objective.